[Central action of a new tranquilizing agent, CS-370 (10-chloro-11b-(2-chlorophenyl)-2,3,5,6,7,11b-hexahydrobenzo(6,7)-1, 4-diazepino(5,4b) oxazol-6-one)].
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003975:Diazepam / Q000494:pharmacology; D004558:Electric Stimulation; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006624:Hippocampus / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology; D007659:Ketones / Q000494:pharmacology; D008297:Male; D008636:Mesencephalon / Q000502:physiology; D009044:Motor Cortex / Q000187:drug effects; D009046:Motor Neurons / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010080:Oxazoles / Q000494:pharmacology; D011817:Rabbits; D012018:Reflex / Q000187:drug effects; D012154:Reticular Formation / Q000502:physiology; D013116:Spinal Cord / Q000187:drug effects; D013787:Thalamic Nuclei / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology*
D001552:Benzazepines; D007659:Ketones; D010080:Oxazoles; D014149:Tranquilizing Agents; D003975:Diazepam